Nymox Pharm Corp (NYMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NYMX | AMGN | BMY | GILD | MRNA |
| Company | Nymox Pharm Corp | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.2200 | 270.63 | 49.00 | 66.58 | 111.05 |
| High | 0.2200 | 274.86 | 49.05 | 67.18 | 111.29 |
| Low | 0.1827 | 269.64 | 48.55 | 66.36 | 106.64 |
| Last | 0.2000 | 273.01 | 48.86 | 67.08 | 108.85 |
| Change | -0.0490 | -0.53 | -0.13 | +0.05 | +0.96 |
| % Change | -19.68% | -0.19% | -0.27% | +0.07% | +0.89% |
| Volume | 932,700 | 2,467,100 | 16,057,141 | 8,466,899 | 3,409,800 |
| 20-Day Average Volume | 309,280 | 2,172,705 | 11,258,950 | 6,490,530 | 3,227,090 |
| Previous Close | 0.2490 | 273.54 | 48.99 | 67.03 | 107.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3282 | 271.55 | 50.37 | 69.07 | 105.22 |
| 20-Day Raw Stochastic | 12.57% | 44.22% | 18.15% | 14.81% | 62.73% |
| 20-Day Relative Strength | 33.51% | 48.18% | 41.15% | 33.12% | 56.47% |
| Weighted Alpha | -62.47 | +11.15 | -26.02 | -20.78 | -8.40 |
| Today's Opinion | 56% Sell | 40% Sell | 88% Sell | 100% Sell | 88% Buy |
| Previous Opinion | 56% Sell | 40% Sell | 88% Sell | 100% Sell | 88% Buy |
| Last Month's Opinion | 32% Buy | 24% Buy | 8% Sell | 88% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -28.98% since 06/28/23 | +3.39% since 04/17/24 | +2.13% since 04/17/24 | +0.22% since 04/17/24 | +5.23% since 04/17/24 |
| Low | 0.1688 on 06/30/23 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 99.30 on 04/22/24 |
| High | 0.3500 on 07/03/23 | 274.86 on 04/24/24 | 49.56 on 04/22/24 | 67.68 on 04/23/24 | 111.29 on 04/24/24 |
| 1-Month | |||||
| %Chg | -50.94% since 06/06/23 | -1.14% since 03/22/24 | -5.91% since 03/22/24 | -7.62% since 03/22/24 | +3.24% since 03/22/24 |
| Low | 0.1688 on 06/30/23 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 97.00 on 04/03/24 |
| High | 0.4170 on 06/16/23 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | -43.80% since 04/06/23 | -10.64% since 01/24/24 | -2.75% since 01/24/24 | -15.65% since 01/24/24 | +7.66% since 01/24/24 |
| Low | 0.1688 on 06/30/23 | 260.68 on 04/19/24 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 84.06 on 02/13/24 |
| High | 0.4950 on 05/08/23 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 81.06 on 01/25/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | -50.73% since 01/06/23 | -1.13% since 10/24/23 | -12.94% since 10/24/23 | -14.17% since 10/24/23 | +36.47% since 10/24/23 |
| Low | 0.1688 on 06/30/23 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 62.55 on 11/02/23 |
| High | 0.5299 on 02/16/23 | 329.72 on 02/05/24 | 56.77 on 10/25/23 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,103 | 146,720,288 | 99,290,928 | 83,457,512 | 41,308,924 |
| Shares Outstanding, K | 90,515 | 536,376 | 2,026,759 | 1,245,077 | 382,880 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -6,580,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | -1,390,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 0.64 | 0.58 | 0.39 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 05/12/23 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 08/21/23 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.58 | 6.55 | 9.96 | 0.00 |